Previous studies have not only described basal/constitutive activation of the JAK2/STAT3 pathway in CLL B lymphocytes, but its inhibition also led to CLL cell death, independent of the protective microenvironment of bone marrow mesenchymal stromal cells [31]. Here, JAK2 is linked to B-cell chronic lymphocytic leukemia.